| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000039381 |
| Receipt No. | R000044882 |
| Scientific Title | Effects of Transcatheter Arterial Micro embolization for Persistent Trapezius Myalgia Refractory to Conservative Treatment: A Retrospective Study |
| Date of disclosure of the study information | 2020/02/03 |
| Last modified on | 2020/02/19 (Ver. 2) |
| Basic information | ||
| Public title | Effects of Transcatheter Arterial Micro embolization for Persistent Trapezius Myalgia Refractory to Conservative Treatment: A Retrospective Study | |
| Acronym | Retrospective study of TAME For TM | |
| Scientific Title | Effects of Transcatheter Arterial Micro embolization for Persistent Trapezius Myalgia Refractory to Conservative Treatment: A Retrospective Study | |
| Scientific Title:Acronym | Retrospective study of TAME For TM | |
| Region |
|
|
| Condition | ||||
| Condition | Trapezius Myalgia | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To clarify the efficacy of TAME for patients with refractory TM |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Clinical success rate at 3 months after treatment |
| Key secondary outcomes | Complications
change of Brief Pain Inventory |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | we perform a retrospective study assessing the clinical course of patients who underwent TAME during 2017 to 2019 | |||
| Key exclusion criteria | none | |||
| Target sample size | 40 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Edogawa Hospital | ||||||
| Division name | MSK Intervention center | ||||||
| Zip code | 133-0052 | ||||||
| Address | 2-24-18, Higashikoiwa, Edogawa-ku, Tokyo | ||||||
| TEL | +81-3-3673-1221 | ||||||
| okuno@okuno-y-clinic.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | MSK Intervention Research Center | ||||||
| Division name | Research Department | ||||||
| Zip code | 107-0062 | ||||||
| Address | 3rd-floor, 2-11-11, Minamiaoyama, Minato-ku, Tokyo, Japan | ||||||
| TEL | +81-3-6801-6539 | ||||||
| Homepage URL | |||||||
| umeki@okuno-y-clinic.com | |||||||
| Sponsor | |
| Institute | MSK Intervention Center, Edogawa Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | non |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Edogawa Hospital |
| Address | 2-24-18, Higashikoiwa, Edogawa-ku, Tokyo |
| Tel | +81-3-3673-1221 |
| secretary@edogawa.or.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | We retrospectively evaluated the prospectively collected data of 42 patients with TM who were treated with TAME between Oct 2017 to 2019 January. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044882 |